References(64)
[1]
Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760.
[2]
Chen, H. B.; Gu, Z. J.; An, H. W.; Chen, C. Y.; Chen, J.; Cui, R.; Chen, S. Q.; Chen, W. H.; Chen, X. S.; Chen, X. Y. et al. Precise nanomedicine for intelligent therapy of cancer. Sci. China Chem. 2018, 61, 1503-1552.
[3]
Zhang, Y.; Cai, L. L.; Li, D.; Lao, Y. H.; Liu, D. Z.; Li, M. Q.; Ding, J. X.; Chen, X. S. Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res. 2018, 11, 4806-4822.
[4]
Piao, J. G.; Gao, F.; Li, Y. N.; Yu, L.; Liu, D.; Tan, Z. B.; Xiong, Y. J.; Yang, L. H.; You, Y. Z. pH-sensitive zwitterionic coating of gold nanocages improves tumor targeting and photothermal treatment efficacy. Nano Res. 2018, 11, 3193-3204.
[5]
Li, Y. J.; Dang, J. J.; Liang, Q. J.; Yin, L. C. Thermal-responsive carbon monoxide (CO) delivery expedites metabolic exhaustion of cancer cells toward reversal of chemotherapy resistance. ACS Cent. Sci. 2019, 5, 1044-1058.
[6]
Zhou, H.; Fan, Z. Y.; Deng, J. J.; Lemons, P. K.; Arhontoulis, D. C.; Bowne, W. B.; Cheng, H. Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy. Nano Lett. 2016, 16, 3268-3277.
[7]
Zhou, H.; Fan, Z. Y.; Li, P. Y.; Deng, J. J.; Arhontoulis, D. C.; Li, C. Y.; Bowne, W. B.; Cheng, H. Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation. ACS Nano 2018, 12, 10130-10141.
[8]
Sun, H. T.; Yan, L. Y.; Chang, M. Y. Z.; Carter, K. A.; Zhang, R. S.; Slyker, L.; Lovell, J. F.; Wu, Y.; Cheng, C. A multifunctional biodegradable brush polymer-drug conjugate for paclitaxel/ gemcitabine co-delivery and tumor imaging. Nanoscale Adv. 2019, 1, 2761-2771.
[9]
Xiong, M. H.; Bao, Y.; Xu, X.; Wang, H.; Han, Z. Y.; Wang, Z. Y.; Liu, Y. Q.; Huang, S. Y.; Song, Z. Y.; Chen, J. J. et al. Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides. Proc. Natl. Acad. Sci. USA 2017, 114, 12675-12680.
[10]
Li, Y. J.; Dang, J. J.; Liang, Q. J.; Yin, L. C. Carbon monoxide (CO)-strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction. Biomaterials 2019, 209, 138-151.
[11]
Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41, 189-207.
[12]
Li, Y. J.; Hu, J.; Liu, X.; Liu, Y.; Lv, S. X.; Dang, J. J.; Ji, Y.; He, J. L.; Yin, L. C. Photodynamic therapy-triggered on-demand drug release from ROS-responsive core-cross-linked micelles toward synergistic anti-cancer treatment. Nano Res. 2019, 12, 999-1008.
[13]
Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 2010, 148, 135-146.
[14]
Li, H. C.; Fan, X. L.; Houghton, J. M. Tumor microenvironment: The role of the tumor stroma in cancer. J. Cell. Biochem. 2007, 101, 805-815.
[15]
Overchuk, M.; Zheng, G. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 2018, 156, 217-237.
[16]
Tong, R.; Langer, R. Nanomedicines targeting the tumor microenvironment. Cancer J. 2015, 21, 314-321.
[17]
Feng, B.; Zhou, F. Y.; Hou, B.; Wang, D. G.; Wang, T. T.; Fu, Y. L.; Ma, Y. T.; Yu, H. J.; Li, Y. P. Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment. Adv. Mater. 2018, 30, 1803001.
[18]
Li, J. J.; Ke, W. D.; Li, H.; Zha, Z. S.; Han, Y.; Ge, Z. S. Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization. Adv. Healthc. Mater. 2015, 4, 2206-2219.
[19]
Chen, B. L.; Dai, W. B.; He, B.; Zhang, H.; Wang, X. Q.; Wang, Y. G.; Zhang, Q. Current multistage drug delivery systems based on the tumor microenvironment. Theranostics 2017, 7, 538-558.
[20]
Zhang, Y. R.; Lin, R.; Li, H. J.; He, W. L.; Du, J. Z.; Wang, J. Strategies to improve tumor penetration of nanomedicines through nanoparticle design. WIREs Nanomed. Nanobiotechnol. 2019, 11, e1519.
[21]
Su, Y. L.; Hu, S. H. Functional nanoparticles for tumor penetration of therapeutics. Pharmaceutics 2018, 10, 193.
[22]
Wang, S.; Huang, P.; Chen, X. Y. Hierarchical targeting strategy for enhanced tumor tissue accumulation/retention and cellular internalization. Adv. Mater. 2016, 28, 7340-7364.
[23]
Niu, Y. M.; Zhu, J. H.; Li, Y.; Shi, H. H.; Gong, Y. X.; Li, R.; Huo, Q.; Ma, T.; Liu, Y. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles. J. Control. Release 2018, 277, 35-47.
[24]
Yin, H.; Yang, J.; Zhang, Q.; Wang, H. Y.; Xu, J. J.; Zheng, J. N. iRGD as a tumor-penetrating peptide for cancer therapy (review). Mol. Med. Rep. 2017, 15, 2925-2930.
[25]
Ruoslahti, E. Tumor penetrating peptides for improved drug delivery. Adv. Drug Deliv. Rev. 2017, 110-111, 3-12.
[26]
Wang, Y. Z.; Xie, Y.; Li, J.; Peng, Z. H.; Sheinin, Y.; Zhou, J. P.; Oupický, D. Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy. ACS Nano 2017, 11, 2227-2238.
[27]
Sun, Q. X.; Ojha, T.; Kiessling, F.; Lammers, T.; Shi, Y. Enhancing tumor penetration of nanomedicines. Biomacromolecules 2017, 18, 1449-1459.
[28]
Xu, X. D.; Er Saw, P.; Tao, W.; Li, Y. J.; Ji, X. Y.; Bhasin, S.; Liu, Y. L.; Ayyash, D.; Rasmussen, J.; Huo, M. et al. ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy. Adv. Mater. 2017, 29, 1700141.
[29]
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 2009, 16, 510-520.
[30]
Su, J. H.; Sun, H. P.; Meng, Q. S.; Yin, Q.; Tang, S.; Zhang, P. C.; Chen, Y.; Zhang, Z. W.; Yu, H. J.; Li, Y. P. Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer. Adv. Funct. Mater. 2016, 26, 1243-1252.
[31]
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. USA 2009, 106, 16157-16162.
[32]
Kuang, J.; Song, W.; Yin, J.; Zeng, X.; Han, S.; Zhao, Y. P.; Tao, J.; Liu, C. J.; He, X. H.; Zhang, X. Z. iRGD modified chemo- immunotherapeutic nanoparticles for enhanced immunotherapy against glioblastoma. Adv. Funct. Mater. 2018, 28, 1800025.
[33]
Cun, X. L.; Chen, J. T.; Ruan, S. B.; Zhang, L.; Wan, J. Y.; He, Q.; Gao, H. L. A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration. ACS Appl. Mater. Interfaces 2015, 7, 27458-27466.
[34]
Puig-Saus, C.; Rojas, L. A.; Laborda, E.; Figueras, A.; Alba, R.; Fillat, C.; Alemany, R. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther. 2014, 21, 767-774.
[35]
Sugahara, K. N.; Teesalu, T.; Prakash Karmali, P.; Ramana Kotamraju, V.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 2010, 328, 1031-1035.
[36]
Su, Y. L.; Yu, T. W.; Chiang, W. H.; Chiu, H. C.; Chang, C. H.; Chiang, C. S.; Hu, S. H. Hierarchically targeted and penetrated delivery of drugs to tumors by size-changeable graphene quantum dot nanoaircrafts for photolytic therapy. Adv. Funct. Mater. 2017, 27, 1700056.
[37]
Li, C. X.; Zhang, Y. F.; Li, Z. M.; Mei, E. C.; Lin, J.; Li, F.; Chen, C. G.; Qing, X. L.; Hou, L. Y.; Xiong, L. L. et al. Light-responsive biodegradable nanorattles for cancer theranostics. Adv. Mater. 2018, 30, 1706150.
[38]
Yang, G. B.; Sun, X. Q.; Liu, J. J.; Feng, L. Z.; Liu, Z. Light- responsive, singlet-oxygen-triggered on-demand drug release from photosensitizer-doped mesoporous silica nanorods for cancer combination therapy. Adv. Funct. Mater. 2016, 26, 4722-4732.
[39]
Tang, L.; Yang, X. J.; Yin, Q.; Cai, K. M.; Wang, H.; Chaudhury, I.; Yao, C.; Zhou, Q.; Kwon, M.; Hartman, J. A. et al. Investigating the optimal size of anticancer nanomedicine. Proc. Natl. Acad. Sci. USA 2014, 111, 15344-15349.
[40]
Tang, L.; Fan, T. M.; Borst, L. B.; Cheng, J. J. Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. ACS Nano 2012, 6, 3954-3966.
[41]
Wang, Z. M.; Upputuri, P. K.; Zhen, X.; Zhang, R. C.; Jiang, Y. Y.; Ai, X. Z.; Zhang, Z. J.; Hu, M.; Meng, Z. Y.; Lu, Y. P. et al. pH-sensitive and biodegradable charge-transfer nanocomplex for second near-infrared photoacoustic tumor imaging. Nano Res. 2019, 12, 49-55.
[42]
Sun, Q. H.; Zhou, Z. X.; Qiu, N. S.; Shen, Y. Q. Rational design of cancer nanomedicine: Nanoproperty integration and synchronization. Adv. Mater. 2017, 29, 1606628.
[43]
Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M. et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6, 815-823.
[44]
Wang, J. Q.; Mao, W. W.; Lock, L. L.; Tang, J. B.; Sui, M. H.; Sun, W. L.; Cui, H. G.; Xu, D.; Shen, Y. Q. The role of micelle size in tumor accumulation, penetration, and treatment. ACS Nano 2015, 9, 7195-7206.
[45]
Sun, Q. H.; Sun, X. R.; Ma, X. P.; Zhou, Z. X.; Jin, E. L.; Zhang, B.; Shen, Y. Q.; Van Kirk, E. A.; Murdoch, W. J.; Lott, J. R. et al. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs. Adv. Mater. 2014, 26, 7615-7621.
[46]
Zhou, J.; Li, M. H.; Lim, W. Q.; Luo, Z.; Phua, S. Z. F.; Huo, R. L.; Li, L. Q.; Li, K.; Dai, L. L.; Liu, J. J. et al. A transferrin-conjugated hollow nanoplatform for redox-controlled and targeted chemotherapy of tumor with reduced inflammatory reactions. Theranostics 2018, 8, 518-532.
[47]
Shen, S.; Li, H. J.; Chen, K. G.; Wang, Y. C.; Yang, X. Z.; Lian, Z. X.; Du, J. Z.; Wang, J. Spatial targeting of tumor-associated macrophages and tumor cells with a pH-sensitive cluster nanocarrier for cancer chemoimmunotherapy. Nano Lett. 2017, 17, 3822-3829.
[48]
Dai, L. L.; Li, K.; Li, M. H.; Zhao, X. J.; Luo, Z.; Lu, L.; Luo, Y. F.; Cai, K. Y. Size/Charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration. Adv. Funct. Mater. 2018, 28, 1707249.
[49]
Li, H. J.; Du, J. Z.; Du, X. J.; Xu, C. F.; Sun, C. Y.; Wang, H. X.; Cao, Z. T.; Yang, X. Z.; Zhu, Y. H.; Nie, S. M. et al. Stimuli- responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc. Natl. Acad. Sci. USA 2016, 113, 4164-4169.
[50]
Chen, J. J.; Ding, J. X.; Wang, Y. C.; Cheng, J. J.; Ji, S. X.; Zhuang, X. L.; Chen, X. S. Sequentially responsive shell-stacked nanoparticles for deep penetration into solid tumors. Adv. Mater. 2017, 29, 1701170.
[51]
Yang, G. B.; Phua, S. Z. F.; Lim, W. Q.; Zhang, R.; Feng, L. Z.; Liu, G. F.; Wu, H. W.; Bindra, A. K.; Jana, D.; Liu, Z. et al. A hypoxia-responsive albumin-based nanosystem for deep tumor penetration and excellent therapeutic efficacy. Adv. Mater. 2019, 31, 1901513.
[52]
Hu, C.; Cun, X. L.; Ruan, S. B.; Liu, R.; Xiao, W.; Yang, X. T.; Yang, Y. Y.; Yang, C. Y.; Gao, H. L. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy. Biomaterials 2018, 168, 64-75.
[53]
Jin, H.; Zhu, T.; Huang, X. G.; Sun, M.; Li, H. G.; Zhu, X. Y.; Liu, M. L.; Xie, Y. B.; Huang, W.; Yan, D. Y. ROS-responsive nanoparticles based on amphiphilic hyperbranched polyphosphoester for drug delivery: Light-triggered size-reducing and enhanced tumor penetration. Biomaterials 2019, 211, 68-80.
[54]
He, H.; Chen, Y. B.; Li, Y. J.; Song, Z. Y.; Zhong, Y. N.; Zhu, R. Y.; Cheng, J. J.; Yin, L. C. Effective and selective anti-cancer protein delivery via all-functions-in-one nanocarriers coupled with visible light-responsive, reversible protein engineering. Adv. Funct. Mater. 2018, 28, 1706710.
[55]
Dang, J. J.; Ye, H.; Li, Y. J.; Liang, Q. J.; Li, X. D.; Yin, L. C. Multivalency-assisted membrane-penetrating siRNA delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism. Biomaterials 2019, 223, 119463.
[56]
Wang, J. H.; He, H.; Xu, X.; Wang, X.; Chen, Y. B.; Yin, L. C. Far-red light-mediated programmable anti-cancer gene delivery in cooperation with photodynamic therapy. Biomaterials 2018, 171, 72-82.
[57]
Zhou, Y.; Ye, H.; Chen, Y. B.; Zhu, R. Y.; Yin, L. C. Photoresponsive drug/gene delivery systems. Biomacromolecules 2018, 19, 1840-1857.
[58]
Xiong, X.; Xu, Z.; Huang, H. B.; Wang, Y.; Zhao, J. Y.; Guo, X.; Zhou, S. B. A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues. Biomaterials 2020, 245, 119840.
[59]
Li, F. Y.; Du, Y.; Liu, J. N.; Sun, H.; Wang, J.; Li, R. Q.; Kim, D.; Hyeon, T.; Ling, D. Responsive assembly of upconversion nanoparticles for pH-activated and near-infrared-triggered photodynamic therapy of deep tumors. Adv. Mater. 2018, 30, 1802808.
[60]
Dang, J. J.; He, H.; Chen, D. L.; Yin, L. C. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater. Sci. 2017, 5, 1500-1511.
[61]
Zhu, R. Y.; He, H.; Liu, Y.; Cao, D. S.; Yan, J.; Duan, S. Z.; Chen, Y. B.; Yin, L. C. Cancer-selective bioreductive chemotherapy mediated by dual hypoxia-responsive nanomedicine upon photodynamic therapy-induced hypoxia aggravation. Biomacromolecules 2019, 20, 2649-2656.
[62]
Ye, H.; Zhou, Y.; Liu, X.; Chen, Y. B.; Duan, S. Z.; Zhu, R. Y.; Liu, Y.; Yin, L. C. Recent advances on reactive oxygen species- responsive delivery and diagnosis system. Biomacromolecules 2019, 20, 2441-2463.
[63]
Nagelkerke, A.; Bussink, J.; Sweep, F. C. G. J.; Span, P. N. Generation of multicellular tumor spheroids of breast cancer cells: How to go three-dimensional. Anal. Biochem. 2013, 437, 17-19.
[64]
Baugh, S. D. P.; Yang, Z. W.; Leung, D. K.; Wilson, D. M.; Breslow, R. Cyclodextrin dimers as cleavable carriers of photodynamic sensitizers. J. Am. Chem. Soc. 2001, 123, 12488-12494.